Michael Malloy

HPV16/18 prevalence in high-grade cervical lesions in an Australian population offered catch-up HPV vaccination

Alyssa M Cornall, Marion Saville, Jan Pyman, Emma T Callegari, Fiona H Tan, Julia Ml Brotherton, Michael J Malloy, Sepehr N Tabrizi, C David Wrede, Suzanne M Garland

Journal article  |  2020  |  Vaccine

OBJECTIVES: Using laser capture microdissection (LCM) and sensitive human papillomavirus (HPV) genotyping, we aimed to determine t..

Assessment of attribution algorithms for resolving CIN3-related HPV genotype prevalence in mixed-genotype biopsy specimens using laser capture microdissection as the reference standard

Alyssa M Cornall, Julia ML Brotherton, Emma T Callegari, Fiona H Tan, Marion Saville, Jan Pyman, Samuel Phillips, Michael J Malloy, Sepehr N Tabrizi, Suzanne M Garland

Journal article  |  2020  |  Vaccine

To make accurate determinations regarding potential and actual impact of HPV vaccine programs, precise estimates of genotype-speci..

Analytical performance of HPV assays on vaginal self -collected vs practitioner -collected cervical samples: the SCoPE study

M Saville, D Hawkes, MHT Keung, ELO Ip, J Silvers, F Sultana, MJ Malloy, LS Velentzis, K Canfel, CD Wrede, JML Brotherton

Journal article  |  2020  |  Journal of Clinical Virology

BACKGROUND: In the last decade, human papillomavirus (HPV) testing has been evaluated extensively for cervical screening, with stu..

Implementation of Australia's renewed cervical screening program: Preparedness of general practitioners and nurses

Farhana Sultana, Lara Roeske, Michael J Malloy, Tracey L McDermott, Marion Saville, Julia ML Brotherton

Journal article  |  2020  |  PLoS One

The National Cervical Screening Program (NCSP) in Australia underwent major changes on December 1st, 2017. The program changed fro..

Compliance with follow-up Test of Cure and outcomes after treatment for high-grade cervical intraepithelial neoplasia in Victoria, Australia

Jeffrey HJ Tan, Michael J Malloy, Julia ML Brotherton, Marion Saville

Journal article  |  2020  |  Australian and New Zealand Journal of Obstetrics and Gynaecology

Is one dose of human papillomavirus vaccine as effective as three?: A national cohort analysis

Julia ML Brotherton, Alison Budd, Christopher Rompotis, Natasha Bartlett, Michael J Malloy, Rachael L Andersen, Kim AR Coulter, Peter W Couvee, Nerida Steel, Gail H Ward, Marion Saville

Journal article  |  2019  |  Papillomavirus Research

AIM: Prophylactic human papillomavirus (HPV) vaccines are highly effective at preventing pre-cancerous cervical lesions when given..

Understanding the participation in cervical screening of Muslim women in Victoria, Australia from record-linkage data

Tahira Yeasmeen, Margaret Kelaher, Julia Ml Brotherton, Michael J Malloy

Journal article  |  2019  |  Journal of Cancer Policy

Management and long-term outcomes of women with adenocarcinoma in situ of the cervix: A retrospective study

Jeffrey HJ Tan, Michael J Malloy, Ramaish Thangamani, Dorota Gertig, Kelly T Drennan, C David Wrede, Marion Saville, Michael Quinn

Journal article  |  2019  |  Australian and New Zealand Journal of Obstetrics and Gynaecology

Clinical Validation of the cobas HPV Test on the cobas 6800 System for the Purpose of Cervical Screening

Marion Saville, Farhana Sultana, Michael J Malloy, Louiza S Velentzis, Michael Caruana, Ellen LO Ip, Marco HT Keung, Karen Canfell, Julia ML Brotherton, David Hawkes

Journal article  |  2019  |  Journal of Clinical Microbiology

Age-specific HPV prevalence among 116,052 women in Australia's renewed cervical screening program: A new tool for monitoring vaccine impact

Julia ML Brotherton, David Hawkes, Farhana Sultana, Michael J Malloy, Dorothy A Machalek, Megan A Smith, Suzanne M Garland, Marion Saville

Journal article  |  2019  |  Vaccine